Paper Details

  1. Home
  2. Paper Details

Effects of calcifediol treatment on the progression of renal osteodystrophy during continuous ambulatory peritoneal dialysis.

Author: BianchiM L, BucciantiG, CresseriD, LorenzM, ValentiG

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Calcifediol treatment improved mineral metabolism in 31 patients with chronic renal failure on CAPD. The treatment normalized calcium levels, decreased alkaline phosphatase and parathyroid hormone, and increased 25-hydroxyvitamin D levels.
Paper Details　
Original Abstract of the Article :
Mineral metabolism was studied in 31 patients with chronic renal failure on continuous ambulatory peritoneal dialysis (CAPD) for a year. After baseline observations, 1-year calcifediol treatment was started in all the patients (100 micrograms/day). After therapy, progressive normalization of calcium...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1159/000186174

データ提供：米国国立医学図書館（NLM）

Calcifediol Treatment for Renal Osteodystrophy

This research investigates the effectiveness of calcifediol treatment in managing renal osteodystrophy, a bone disease that often occurs in patients with chronic renal failure undergoing continuous ambulatory peritoneal dialysis (CAPD). The study examines the impact of calcifediol on mineral metabolism and bone health in these patients, providing insights into its potential role in improving bone health in individuals with chronic kidney disease.

Calcifediol's Positive Effects on Mineral Metabolism

The study demonstrates the positive effects of calcifediol treatment on mineral metabolism in patients with chronic renal failure undergoing CAPD. The research found that calcifediol effectively normalized calcium levels, reduced plasma alkaline phosphatase and parathyroid hormone, and improved bone mineral density and bone biopsy indexes. These findings suggest that calcifediol can be a valuable tool in managing the metabolic disturbances associated with renal osteodystrophy.

Improving Bone Health in Chronic Kidney Disease

This research provides valuable information for managing bone health in patients with chronic kidney disease. The study demonstrates the effectiveness of calcifediol in addressing the mineral imbalances and bone abnormalities often associated with renal osteodystrophy. This is like providing a refreshing oasis for the bones, helping to restore balance and promote healthy growth.

Dr. Camel's Conclusion

This research sheds light on the importance of addressing mineral metabolism in patients with chronic kidney disease. The study demonstrates the beneficial effects of calcifediol in managing renal osteodystrophy, offering a beacon of hope in the desert of chronic kidney disease. This study underscores the need for proactive management of bone health in individuals with chronic kidney disease, a vital step in promoting overall well-being.
Date :
  1. Date Completed 1991-05-01
  2. Date Revised 2018-02-15
Further Info :

Pubmed ID

2079992

DOI: Digital Object Identifier

10.1159/000186174

Related Literature

Article Analysis
・Effects of calcifediol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.